The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Chromosomal Microarray (CMA) Testing Market Research Report 2024
Synopsis
Chromosomal Microarray (CMA) Testing is a genetic diagnostic technique that uses microarray technology to analyze an individual's DNA for chromosomal abnormalities, structural variations, and genetic disorders.
Global Chromosomal Microarray (CMA) Testing market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Chromosomal Microarray (CMA) Testing market research.
The advancement of genetic testing technologies drives the adoption of CMA testing. Healthcare providers, especially in prenatal and pediatric fields, rely on CMA to identify genetic causes of developmental and intellectual disabilities.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Chromosomal Microarray (CMA) Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Baylor Genetics
MedGenome Labs
Centogene
GeneDx
Quest Diagnostics
LabCorp
Lineagen
Invitae
Illumina Inc.
CD Genomics
Thermo Fisher
Agilent
Segment by Type
Single Nucleotide Polymorphism (SNP)
Comparative Genomic Hybridization (CGH)
Segment by Application
Medical
Laboratory
Clinical
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Chromosomal Microarray (CMA) Testing report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Chromosomal Microarray (CMA) Testing is a genetic diagnostic technique that uses microarray technology to analyze an individual's DNA for chromosomal abnormalities, structural variations, and genetic disorders.
Global Chromosomal Microarray (CMA) Testing market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Chromosomal Microarray (CMA) Testing market research.
The advancement of genetic testing technologies drives the adoption of CMA testing. Healthcare providers, especially in prenatal and pediatric fields, rely on CMA to identify genetic causes of developmental and intellectual disabilities.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Chromosomal Microarray (CMA) Testing market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Baylor Genetics
MedGenome Labs
Centogene
GeneDx
Quest Diagnostics
LabCorp
Lineagen
Invitae
Illumina Inc.
CD Genomics
Thermo Fisher
Agilent
Segment by Type
Single Nucleotide Polymorphism (SNP)
Comparative Genomic Hybridization (CGH)
Segment by Application
Medical
Laboratory
Clinical
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Chromosomal Microarray (CMA) Testing report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chromosomal Microarray (CMA) Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Single Nucleotide Polymorphism (SNP)
1.2.3 Comparative Genomic Hybridization (CGH)
1.3 Market by Application
1.3.1 Global Chromosomal Microarray (CMA) Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Medical
1.3.3 Laboratory
1.3.4 Clinical
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Chromosomal Microarray (CMA) Testing Market Perspective (2018-2029)
2.2 Chromosomal Microarray (CMA) Testing Growth Trends by Region
2.2.1 Global Chromosomal Microarray (CMA) Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Chromosomal Microarray (CMA) Testing Historic Market Size by Region (2018-2023)
2.2.3 Chromosomal Microarray (CMA) Testing Forecasted Market Size by Region (2024-2029)
2.3 Chromosomal Microarray (CMA) Testing Market Dynamics
2.3.1 Chromosomal Microarray (CMA) Testing Industry Trends
2.3.2 Chromosomal Microarray (CMA) Testing Market Drivers
2.3.3 Chromosomal Microarray (CMA) Testing Market Challenges
2.3.4 Chromosomal Microarray (CMA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chromosomal Microarray (CMA) Testing Players by Revenue
3.1.1 Global Top Chromosomal Microarray (CMA) Testing Players by Revenue (2018-2023)
3.1.2 Global Chromosomal Microarray (CMA) Testing Revenue Market Share by Players (2018-2023)
3.2 Global Chromosomal Microarray (CMA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chromosomal Microarray (CMA) Testing Revenue
3.4 Global Chromosomal Microarray (CMA) Testing Market Concentration Ratio
3.4.1 Global Chromosomal Microarray (CMA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chromosomal Microarray (CMA) Testing Revenue in 2022
3.5 Chromosomal Microarray (CMA) Testing Key Players Head office and Area Served
3.6 Key Players Chromosomal Microarray (CMA) Testing Product Solution and Service
3.7 Date of Enter into Chromosomal Microarray (CMA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chromosomal Microarray (CMA) Testing Breakdown Data by Type
4.1 Global Chromosomal Microarray (CMA) Testing Historic Market Size by Type (2018-2023)
4.2 Global Chromosomal Microarray (CMA) Testing Forecasted Market Size by Type (2024-2029)
5 Chromosomal Microarray (CMA) Testing Breakdown Data by Application
5.1 Global Chromosomal Microarray (CMA) Testing Historic Market Size by Application (2018-2023)
5.2 Global Chromosomal Microarray (CMA) Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Chromosomal Microarray (CMA) Testing Market Size (2018-2029)
6.2 North America Chromosomal Microarray (CMA) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Chromosomal Microarray (CMA) Testing Market Size by Country (2018-2023)
6.4 North America Chromosomal Microarray (CMA) Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Chromosomal Microarray (CMA) Testing Market Size (2018-2029)
7.2 Europe Chromosomal Microarray (CMA) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Chromosomal Microarray (CMA) Testing Market Size by Country (2018-2023)
7.4 Europe Chromosomal Microarray (CMA) Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chromosomal Microarray (CMA) Testing Market Size (2018-2029)
8.2 Asia-Pacific Chromosomal Microarray (CMA) Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Chromosomal Microarray (CMA) Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Chromosomal Microarray (CMA) Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Chromosomal Microarray (CMA) Testing Market Size (2018-2029)
9.2 Latin America Chromosomal Microarray (CMA) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Chromosomal Microarray (CMA) Testing Market Size by Country (2018-2023)
9.4 Latin America Chromosomal Microarray (CMA) Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chromosomal Microarray (CMA) Testing Market Size (2018-2029)
10.2 Middle East & Africa Chromosomal Microarray (CMA) Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Chromosomal Microarray (CMA) Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Chromosomal Microarray (CMA) Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Baylor Genetics
11.1.1 Baylor Genetics Company Detail
11.1.2 Baylor Genetics Business Overview
11.1.3 Baylor Genetics Chromosomal Microarray (CMA) Testing Introduction
11.1.4 Baylor Genetics Revenue in Chromosomal Microarray (CMA) Testing Business (2018-2023)
11.1.5 Baylor Genetics Recent Development
11.2 MedGenome Labs
11.2.1 MedGenome Labs Company Detail
11.2.2 MedGenome Labs Business Overview
11.2.3 MedGenome Labs Chromosomal Microarray (CMA) Testing Introduction
11.2.4 MedGenome Labs Revenue in Chromosomal Microarray (CMA) Testing Business (2018-2023)
11.2.5 MedGenome Labs Recent Development
11.3 Centogene
11.3.1 Centogene Company Detail
11.3.2 Centogene Business Overview
11.3.3 Centogene Chromosomal Microarray (CMA) Testing Introduction
11.3.4 Centogene Revenue in Chromosomal Microarray (CMA) Testing Business (2018-2023)
11.3.5 Centogene Recent Development
11.4 GeneDx
11.4.1 GeneDx Company Detail
11.4.2 GeneDx Business Overview
11.4.3 GeneDx Chromosomal Microarray (CMA) Testing Introduction
11.4.4 GeneDx Revenue in Chromosomal Microarray (CMA) Testing Business (2018-2023)
11.4.5 GeneDx Recent Development
11.5 Quest Diagnostics
11.5.1 Quest Diagnostics Company Detail
11.5.2 Quest Diagnostics Business Overview
11.5.3 Quest Diagnostics Chromosomal Microarray (CMA) Testing Introduction
11.5.4 Quest Diagnostics Revenue in Chromosomal Microarray (CMA) Testing Business (2018-2023)
11.5.5 Quest Diagnostics Recent Development
11.6 LabCorp
11.6.1 LabCorp Company Detail
11.6.2 LabCorp Business Overview
11.6.3 LabCorp Chromosomal Microarray (CMA) Testing Introduction
11.6.4 LabCorp Revenue in Chromosomal Microarray (CMA) Testing Business (2018-2023)
11.6.5 LabCorp Recent Development
11.7 Lineagen
11.7.1 Lineagen Company Detail
11.7.2 Lineagen Business Overview
11.7.3 Lineagen Chromosomal Microarray (CMA) Testing Introduction
11.7.4 Lineagen Revenue in Chromosomal Microarray (CMA) Testing Business (2018-2023)
11.7.5 Lineagen Recent Development
11.8 Invitae
11.8.1 Invitae Company Detail
11.8.2 Invitae Business Overview
11.8.3 Invitae Chromosomal Microarray (CMA) Testing Introduction
11.8.4 Invitae Revenue in Chromosomal Microarray (CMA) Testing Business (2018-2023)
11.8.5 Invitae Recent Development
11.9 Illumina Inc.
11.9.1 Illumina Inc. Company Detail
11.9.2 Illumina Inc. Business Overview
11.9.3 Illumina Inc. Chromosomal Microarray (CMA) Testing Introduction
11.9.4 Illumina Inc. Revenue in Chromosomal Microarray (CMA) Testing Business (2018-2023)
11.9.5 Illumina Inc. Recent Development
11.10 CD Genomics
11.10.1 CD Genomics Company Detail
11.10.2 CD Genomics Business Overview
11.10.3 CD Genomics Chromosomal Microarray (CMA) Testing Introduction
11.10.4 CD Genomics Revenue in Chromosomal Microarray (CMA) Testing Business (2018-2023)
11.10.5 CD Genomics Recent Development
11.11 Thermo Fisher
11.11.1 Thermo Fisher Company Detail
11.11.2 Thermo Fisher Business Overview
11.11.3 Thermo Fisher Chromosomal Microarray (CMA) Testing Introduction
11.11.4 Thermo Fisher Revenue in Chromosomal Microarray (CMA) Testing Business (2018-2023)
11.11.5 Thermo Fisher Recent Development
11.12 Agilent
11.12.1 Agilent Company Detail
11.12.2 Agilent Business Overview
11.12.3 Agilent Chromosomal Microarray (CMA) Testing Introduction
11.12.4 Agilent Revenue in Chromosomal Microarray (CMA) Testing Business (2018-2023)
11.12.5 Agilent Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
